Expression of Human Beta-defensins 1 and 2 in Kidneys with Chronic Bacterial Infection

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2002 Sep 20

PMID 12238953

Citations 41

Authors

Jan Lehmann

Margitta Retz

Jurgen Harder

Matthias Krams

Udo Kellner

Julia Hartmann

Kerstin Hohgrawe

Uta Raffenberg

Martin Gerber

Tillmann Loch

Klaus Weichert-Jacobsen

Michael Stockle

Affiliations

Soon will be listed here.

Abstract

Background: Constitutive expression and localization of antimicrobial human beta-defensin-1 (HBD-1) in human kidneys as a potential mechanism of antimicrobial defense has been previously reported. Inducible expression of human beta-defensin-2 (HBD-2) has been described in various epithelial organs but not for the urogenital tract.

Methods: We investigated the gene- and protein expression of HBD-1 and HBD-2 by reverse transcriptase-polymerase chain reaction, and immunohistochemistry in 15 normal human kidney samples and 15 renal tissues with chronic bacterial infection. Additionally, cell culture experiments were performed to study HBD gene expression by real-time RT-PCR in response to inflammatory cytokines TNFalpha and IL-1beta as well as lipopolysaccharide from Gram-negative bacteria.

Results: Constitutive HBD-1 gene- and protein expression was detected in normal renal tissue and kidneys with chronic infection. As a novel finding, inducible HBD-2 gene- and protein expression was demonstrated in tubulus epithelia with chronic infection but not in normal renal tissue. In pyelonephritic kidneys HBD-1 and HBD-2 expression showed a similar pattern of localization in distal tubules, loops of Henle and in collecting ducts of the kidney. Furthermore, real-time RT-PCR of kidney derived cell lines stimulated with inflammatory agents TNF-alpha, IL-1beta and LPS revealed a strong increase in relative HBD-2 transcription level and also a slight increase in relative HBD-1 transcription level.

Conclusions: Upregulated HBD-2 expression in renal tubulus epithelium indicates a role of a wider range of human defensins for antimicrobial host defense in the urogenital tract than previously recognized.

Citing Articles

Secretory leukocyte protease inhibitor protects against severe urinary tract infection in mice.

Rosen A, Lint M, Voelker D, Gilbert N, Tomera C, Santiago-Borges J mBio. 2024; 15(2):e0255423.

PMID: 38270443 PMC: 10865866. DOI: 10.1128/mbio.02554-23.

Establishment of Baseline Urinary Antimicrobial Peptide Levels by Age: A Prospective Observational Study.

Caterino J, Stephens J, Wexler R, Camargo Jr C, Hunold K, Wei L J Gerontol A Biol Sci Med Sci. 2023; 79(6).

PMID: 37708314 PMC: 11083632. DOI: 10.1093/gerona/glad223.

Immune defenses in the urinary tract.

Kuhn H, Hreha T, Hunstad D Trends Immunol. 2023; 44(9):701-711.

PMID: 37591712 PMC: 10528756. DOI: 10.1016/j.it.2023.07.001.

Understanding the Roles of Host Defense Peptides in Immune Modulation: From Antimicrobial Action to Potential as Adjuvants.

Kim J, Cho B, Jang Y J Microbiol Biotechnol. 2023; 33(3):288-298.

PMID: 36775853 PMC: 10084754. DOI: 10.4014/jmb.2301.01005.

Human β-Defensin 2 and Its Postulated Role in Modulation of the Immune Response.

Cieslik M, Baginska N, Gorski A, Jonczyk-Matysiak E Cells. 2021; 10(11).

PMID: 34831214 PMC: 8616480. DOI: 10.3390/cells10112991.

References

Schroder J . Epithelial antimicrobial peptides: innate local host response elements. Cell Mol Life Sci. 2001; 56(1-2):32-46. PMC: 11147007. DOI: 10.1007/s000180050004. View

ONeil D, Porter E, Elewaut D, Anderson G, Eckmann L, Ganz T . Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol. 1999; 163(12):6718-24. View

Garcia J, Krause A, Schulz S, Rodriguez-Jimenez F, Kluver E, Adermann K . Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 2001; 15(10):1819-21. View

Paulsen F, Pufe T, Schaudig U, Held-Feindt J, Lehmann J, Schroder J . Detection of natural peptide antibiotics in human nasolacrimal ducts. Invest Ophthalmol Vis Sci. 2001; 42(10):2157-63. View

Garcia J, Jaumann F, Schulz S, Krause A, Rodriguez-Jimenez J, Forssmann U . Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 2001; 306(2):257-64. DOI: 10.1007/s004410100433. View

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

Cohen M, Britigan B, French M, Bean K . Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. Am J Obstet Gynecol. 1987; 157(5):1122-5. DOI: 10.1016/s0002-9378(87)80274-0. View

Newbold R, TENG C, Beckman Jr W, Jefferson W, Hanson R, Miller J . Fluctuations of lactoferrin protein and messenger ribonucleic acid in the reproductive tract of the mouse during the estrous cycle. Biol Reprod. 1992; 47(5):903-15. DOI: 10.1095/biolreprod47.5.903. View

Bensch K, Raida M, Magert H, Schulz-Knappe P, Forssmann W . hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 1995; 368(2):331-5. DOI: 10.1016/0014-5793(95)00687-5. View

10.

Harder J, Bartels J, Christophers E, Schroder J . A peptide antibiotic from human skin. Nature. 1997; 387(6636):861. DOI: 10.1038/43088. View

11.

Ganz T, Lehrer R . Antimicrobial peptides of vertebrates. Curr Opin Immunol. 1998; 10(1):41-4. DOI: 10.1016/s0952-7915(98)80029-0. View

12.

Valore E, Park C, Quayle A, Wiles K, McCray Jr P, Ganz T . Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest. 1998; 101(8):1633-42. PMC: 508744. DOI: 10.1172/JCI1861. View

13.

Zucht H, Grabowsky J, Schrader M, Liepke C, Jurgens M, Schulz-Knappe P . Human beta-defensin-1: A urinary peptide present in variant molecular forms and its putative functional implication. Eur J Med Res. 1998; 3(7):315-23. View

14.

Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M . Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest. 1998; 102(5):874-80. PMC: 508952. DOI: 10.1172/JCI2410. View

15.

Weinberg A, Krisanaprakornkit S, Dale B . Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med. 1998; 9(4):399-414. DOI: 10.1177/10454411980090040201. View

16.

Singh P, Jia H, Wiles K, Hesselberth J, Liu L, Conway B . Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A. 1998; 95(25):14961-6. PMC: 24558. DOI: 10.1073/pnas.95.25.14961. View

17.

Schnapp D, Reid C, Harris A . Localization of expression of human beta defensin-1 in the pancreas and kidney. J Pathol. 1999; 186(1):99-103. DOI: 10.1002/(SICI)1096-9896(199809)186:1<99::AID-PATH133>3.0.CO;2-#. View

18.

Schroder J . Epithelial peptide antibiotics. Biochem Pharmacol. 1999; 57(2):121-34. DOI: 10.1016/s0006-2952(98)00226-3. View

19.

Cole A, Dewan P, Ganz T . Innate antimicrobial activity of nasal secretions. Infect Immun. 1999; 67(7):3267-75. PMC: 116505. DOI: 10.1128/IAI.67.7.3267-3275.1999. View

20.

Schroder J, Harder J . Human beta-defensin-2. Int J Biochem Cell Biol. 1999; 31(6):645-51. DOI: 10.1016/s1357-2725(99)00013-8. View